Activation of PPARG expression may inhibit the progression of LSCC through the regulation of LSCC upstream regulators and downstream marker genes involved in tumor cell proliferation and protein polyubiquitination/ubiquitination [44]. The gene discussed is PPARG; the disease is neoplasm.